A Priority FDA Review for Toremifene 80 mg for Bone Protection

GTx announced in a company media release that it has requested that the FDA consider its new drug application (NDA) for the use of toremifene 80 mg to prevent bone fractures in men with prostate cancer receiving androgen deprivation therapy (ADT). GTx has asked for a priority review of its application stating that “there are [...]

The True Value of Flaxseeds with Prostate cancer

According to a study at Duke University Medical Center flaxseed stunts the growth of prostate tumors. Flaxseeds, rich in omega 3-fatty acids and lignans (a fiber-related compound) has demonstrated the ability to halt prostate tumor growth. The sesame seed like flaxseed seems to be able to interrupt the chain of events that leads cells to [...]

Living Day to Day (Living by PSA)- An Installment of Scott Goodwin’s Personal Experience with Chemotherapy

I completed my third treatment on Christmas Eve. I felt pretty good through the holiday weekend but started to fade a little by Sunday. The major side effect at this point is fatigue. As most of you know taking a nap doesn't always help, but still feels good. Despite the treatment we are on, we [...]

Dutasteride (Avodart) Provides No Clinical Benefit to Men with Recurrent Castrate Resistant Prostate Cancer

At the University of New Mexico School of Medicine in Albuquerque, New Mexico (SKS) the Department of Urology just completed a study that showed that dutasteride, the generic name for a dual 5alpha-reductase inhibitor made by GlaxoSmithKline and marketed under the name Avodart™ in the US and Avolve™ in Europe, when administered to men with [...]

Go to Top